Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: October 2014

Chapter 15 - Eliciting axioms to enrich debates about the pharmaceutical industry

from Section 2 - VBM and the basis for medical decisions: survival, security and flourishing

References

Angell, M. (2004) The Truth About the Drug Companies: How they deceive us and what to do about it. New York: Random House.
Bekelman, J., Li, Y.et al. (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. Journal of the American Medical Association, 289(4), 454–465.
Charmaz, K. (2006) Constructing Grounded Theory: A practical guide through qualitative analysis. London: Sage.
DeMartino, J. K. (2012) The Physician Payment Sunshine Act. Journal of the National Comprehensive Cancer Network, 10(3), 423–424.
Elliot, C. (2010) White Coat, Black Hat: Adventures on the dark side of medicine. Boston, MA: Beacon Press.
Lo, B. (2012) The future of conflicts of interest: a call for professional standards. Journal of Law Medicine and Ethics, 40(3), 441–451.
MacIntyre, A. (editor) (1993) After Virtue – A Study in Moral Theory. London: Duckworth.
Martin, E. (2006) Pharmaceutical virtue. Culture, Medicine and Psychiatry, 30, 157–174.
McCarthy, T. (1978) The Critical Theory of Jurgen Habermas. Cambridge, MA: MIT Press.
Morse, J. M. (1994) Emerging from the data: the cognitive processes of analysis in qualitative inquiry. Critical Issues in Qualitative Research Methods, pp. 23–42. Thousand Oaks: Sage.
Nussbaum, M. (1995) Non-relative virtues: an Aristotelian approach. In Nussbaum, M. and Sen, A. (editors), The Quality of Life, pp. 242–269. Oxford: Clarendon Press.
Pellegrino, E. and Thomasma, D. (1993) The Virtues in Medical Practice. New York: Oxford University Press.
Raad, R. and Appelbaum, P. S. (2012) Relationships between medicine and industry: approaches to the problem of conflicts of interest. Annual Review of Medicine, 63, 465–477.
Roberts, J. M. (2012) Discourse or dialogue? Habermas, the Bakhtin Circle, and the question of concrete utterances. Theory and Society, 41(4), 395–419.
Schulman, K., Seils, D.et al. (2002) A national survey of provisions in clinical trial agreements between medical schools and industry sponsors. New England Journal of Medicine, 347(17), 1335–1341.
Shapin, S. (2008) The Scientific Life: a moral history of a late modern vocation. Chicago, IL: University of Chicago Press.
Stossel, T. P. and Stell, L. K. (2011) Time to ‘walk the walk’ about industry ties to enhance health. Nature Medicine, 17(4), 437–438.